Stockscreener 앱 받기
26.02
2.00%
-0.53
시간 외 거래:
26.02
전일 마감가:
$26.55
열려 있는:
$26.23
하루 거래량:
360.76K
Relative Volume:
0.52
시가총액:
$2.01B
수익:
$1.53B
순이익/손실:
$40.23M
주가수익비율:
52.04
EPS:
0.5
순현금흐름:
$60.93M
1주 성능:
-1.21%
1개월 성능:
+19.91%
6개월 성능:
+14.22%
1년 성능:
-36.57%
1일 변동 폭
$25.86
$26.98
1주일 범위
$25.32
$26.98
52주 변동 폭
$16.80
$45.42
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
명칭
Integra Lifesciences Holdings Corp
전화
(609) 275-0500
주소
1100 CAMPUS ROAD, PRINCETON, NJ
IART을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
26.02 | 2.01B | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 개시 | Morgan Stanley | Underweight |
| 2024-10-07 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2024-07-30 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-07-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-05-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-12-05 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 개시 | CL King | Buy |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-08 | 다운그레이드 | Argus | Buy → Hold |
| 2023-05-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-25 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2021-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 개시 | Citigroup | Neutral |
| 2020-04-03 | 개시 | SunTrust | Buy |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 개시 | SunTrust | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-07 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-07-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Neutral |
| 2018-01-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 개시 | UBS | Buy |
모두보기
Integra Lifesciences Holdings Corp 주식(IART)의 최신 뉴스
Grabar Law Office is Investigating Claims on Behalf of - GlobeNewswire
EVP, Chief Legal Officer & Sec, Schwartz Eric sold 4,070 shares of Integra Lifesciences Holdings Corp [IART] - Knox Daily
Global Electrosurgery Generators Market on a Growth Trajectory, Expected to Reach USD 3,359.2 Million by 2035 | Future Market Insights, Inc. - GlobeNewswire Inc.
Notice To Long-Term Integra Lifesciences Holdings - GlobeNewswire
Ready to Jump After Recent Trade: Integra Lifesciences Holdings Corp (IART) - SETE News
Integra LifeSciences to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on February 25, 2025 - Yahoo Finance
Short Interest in Integra LifeSciences Holdings Co. (NASDAQ:IART) Drops By 6.1% - MarketBeat
Analysts Set Integra LifeSciences Holdings Co. (NASDAQ:IART) PT at $23.00 - MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives Average Rating of “Reduce” from Brokerages - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Stock Holdings Decreased by Assenagon Asset Management S.A. - Defense World
Is Integra LifeSciences (IART) Stock Undervalued Right Now? - Yahoo Finance
Implied Volatility Surging for Integra LifeSciences (IART) Stock Options - MSN
Integra LifeSciences Holdings Co. (NASDAQ:IART) Short Interest Down 6.1% in December - MarketBeat
Dura Substitutes Market Analysis Report 2025, with Leading Player Analysis for Medtronic, B. Braun, Stryker, DePuy Synthes, Acera Surgical, Severn Healthcare Technologies, Integra Lifesciences & Gunze - Yahoo Finance UK
Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs) - Yahoo Finance
Non-Invasive Intracranial Pressure Monitoring Devices Market to Grow by USD 126.1 Million from 2025-2029, Driven by Increased Awareness and AI's Impact on Market TrendsTechnavio - The Malaysian Reserve
Integra LifeSciences receives FDA warning letter By Investing.com - Investing.com Australia
Implied Volatility Surging For Integra LifeSciences (IART) Stock Options - Barchart
Integra LifeSciences receives FDA warning letter - Investing.com
Is Integra LifeSciences (IART) a Great Value Stock Right Now? - Yahoo Finance
Principal Financial Group Inc. Buys 63,266 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Geode Capital Management LLC Sells 3,854 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Insider Stock Buying Reaches US$2.50m On Integra LifeSciences Holdings - Yahoo Finance
Here’s Why Integra LifeSciences Holdings Corporation (IART) Fell in Q3 - Yahoo Finance
Integra LifeSciences sets new executive severance terms - Investing.com
Comparing Integra LifeSciences (NASDAQ:IART) and Alpha Tau Medical (NASDAQ:DRTS) - Defense World
Fmr LLC Trims Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Recommendation of “Reduce” by Brokerages - Defense World
Sachem Head Capital Management LP Makes New Investment in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Integra LifeSciences EVP Eric Schwartz sells $100,101 in stock By Investing.com - Investing.com Nigeria
Integra LifeSciences EVP Eric Schwartz sells $100,101 in stock - Investing.com India
Insider Sell Alert: Eric Schwartz Sells Shares of Integra Lifesc - GuruFocus.com
Insider Sell: Michael Mcbreen Sells Shares of Integra Lifescienc - GuruFocus.com
Thrivent Financial for Lutherans Trims Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Bridgewater Associates LP Sells 83,807 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Walleye Capital LLC Increases Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Bought by Quantbot Technologies LP - MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Victory Capital Management Inc. - Defense World
Rubric Capital Management LP Purchases New Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat
Regenerative Medicine Market to grow by USD 70.11 Billion (2024-2028), rising prevalence of chronic diseases to drive revenue, Report with AI-powered insightsTechnavio - The Malaysian Reserve
Minimally Invasive Neurosurgical Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 - GlobalData
Integra Lifesciences (IART) Stock Dips Amid Financial Concerns - GuruFocus.com
Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research - Yahoo Finance
Fuller & Thaler Asset Management, Inc. Expands Stake in Integra Lifesciences Holdings Corp - GuruFocus.com
Capital Research Global Investors Reduces Stake in Integra Lifes - GuruFocus.com
Integra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
Integra LifeSciences : Serving Those Who Served - Marketscreener.com
Integra Lifesciences Holdings Corp (IART) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.14%
2.09%
자본화:
|
볼륨(24시간):